In a recent study published in the journal Obstetrics & Gynecology , researchers evaluate the association between antenatal coronavirus disease 2019 (COVID-19) vaccination and adverse pregnancy outcomes. Study: Obstetric complications and birth outcomes after antenatal coronavirus disease 2019 (COVID-19) vaccination. Image Credit: Anuta23 / Shutterstock.
com Most individuals infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen responsible for COVID-19, experience mild symptoms or remain asymptomatic throughout the infection. However, certain patient populations, such as older adults, those with certain comorbidities, and pregnant women, are at an increased overall risk of mortality and morbidity when infected with SARS-CoV-2. In pregnant women, COVID-19 increases the risk of cesarean delivery, hypertensive disorders of pregnancy (HDP), and preterm birth (PTB).
Despite being excluded from the initial clinical trials on COVID-19 vaccines, pregnant women were advised to be vaccinated against COVID-19. Soon after their approval and subsequent distribution to the public, messenger ribonucleic acid (mRNA) COVID-19 vaccines were found to significantly reduce the risk of COVID-19-related complications in both pregnant women and their infants during the first six months of life. Nevertheless, there remains a lack of data on how antenatal COVID-19 vaccination affects the risk of adverse pregnancy outcomes.
To this end, the current study aimed to e.
